首页>
外文期刊>Pediatric Research
>Comparative Effects of Tin- and Zinc-Protoporphyrin on Steroidogenesis: Tin-Protoporphyrin is a Potent Inhibitor of Cytochrome P-450-Dependent Activities in the Rat Adrenals
【24h】
Comparative Effects of Tin- and Zinc-Protoporphyrin on Steroidogenesis: Tin-Protoporphyrin is a Potent Inhibitor of Cytochrome P-450-Dependent Activities in the Rat Adrenals
Synthetic metalloporphyins inhibit formation of bilirubin by the heme oxygenase system, an ability that is of considerable experimental and clinical interest for suppression of jaundice in the newborn. The present investigation compares the consequences of treatment with Sn- and Zn-protoporphyrin on hemoprotein-dependent enzymes of the rat adrenals and corticosterone production and defines Sn-protoporphyrin as a potent toxin to adrenal functions. Treatment of rats with Sn-protoporphyrin (two doses of 50 μmol/kg, in 7 d) resulted in a marked reduction of 30–40% in cytochrome P-450-dependent adrenal microsomal 21α-hydroxylase and mitochondrial 11β-hydroxylase activities. In the serum, the levels of corticosterone were reduced to about 70% of the control value. In addition, the mitochondrial cytochrome P-450SCC activity was decreased by about 50%. This decrease, however, could not be attributed to a reduced total heme level or an accelerated heme degradatory activity. Disruption by Sn-protoporphyrin of adrenal hemoprotein-dependent functions was not restricted to steroidogenic activities and encompassed drug metabolism activity of the organ; benzo(a)pyrene hydroxylase activity of both the microsomal and the mitochondrial fractions, as well as the microsomal NADPH-cytochrome P-450 reductase activity, were significantly reduced. Zn-protoporphyrin did not cause significant alterations in the above measured parameters although it too was effective in inhibiting the hepatic microsomal heme oxygenase activity. In light of the presently defined adverse effects of Sn-protoporphyrin on adrenal Steroidogenesis, we suggest Zn-protoporphyrin is the agent of choice for potential use in treatment of hyperbilirubinemia in humans.
展开▼
